Loading clinical trials...
Loading clinical trials...
Chronic kidney disease (CKD) is a major health problem, with steadily increasing incidence and prevalence and the threat of a true "epidemic". Converging evidence suggests a high prevalence of genetic etiology in rare kidney diseases and the list of new disease-causing genes is constantly updated. Recent advances in next-generation sequencing (NGS) technologies have prompted a significant improvement in the diagnosis of rare kidney diseases. Notwithstanding this, NGS generates high numbers of information that need to be properly analysed by the joint efforts of geneticists, nephrologists and bioinformatics in order to integrate clinical and genetic information in a personalized manner. In addition, in selected cases, the contribution of researchers proves essential for the development of experimental models of the disease to study and understand the pathogenic features and propose a personalized therapeutic approach. Such an innovative, integrated diagnostic paradigm is currently available in few centers all over the world and cannot be easily translated in daily clinical practice. The aim of the study is to set-up an integrated diagnostic algorithm to extend the newest personalized diagnostic and treatment strategies for rare kidney diseases to all patients in the Tuscany region, under 40 years of age with kidney disease. This algorithm will be based on a constant cross-talk between participating centers and a dedicated multidisciplinary team. Diagnostic and therapeutic performances will be validated at European level.
Age
0 - 40 years
Sex
ALL
Healthy Volunteers
No
Azienda Ospedaliero Universitaria Careggi
Florence, Italy
Meyer Children's Hospital IRCCS
Florence, Italy
USL Toscana Centro
Florence, Italy
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy
Start Date
July 9, 2021
Primary Completion Date
June 27, 2023
Completion Date
June 30, 2024
Last Updated
March 22, 2024
160
ESTIMATED participants
Conclusive genetic testing
DIAGNOSTIC_TEST
Genotype-phenotype correlation for personalized diagnosis
DIAGNOSTIC_TEST
Personalized study of variants of uncertain clinical significance (VUS) through functional studies on 3D organ-on-a-chip
DIAGNOSTIC_TEST
Lead Sponsor
Meyer Children's Hospital IRCCS
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07358572